A round-up of the latest products hitting the dermatology market including treatment for eczema and wounds, plus care for rejuvenating procedures.
This summer, new OTC solutions for eczema and woundcare were introduced. The SkinSmart Antimicrobial Eczema Therapy and Wound Therapy are topical sprays that use a proprietary hypochlorous acid solution, which eliminates irritating microorganisms to soothe the skin and promote healing, the company says. Both solutions are free of steroids, alcohol, fragrance, dyes and perfumes. They are hypoallergenic, non-toxic and non-irritating.
FOR MORE INFORMATION: http://skinsmartantimicrobial.com
A topical cannabis cream launched by MedRelief in Canada in early October, which “could offer significant relief to [Canadian] patients suffering from pain and itch in a number of inflammatory dermatoses,” said Jaggi Rao, M.D., in the company’s press release. He is a dermatologist and clinical professor of medicine at the University of Alberta. MedReleaf’s topical cream uses cosmetic grade ingredients and is approved by Health Canada for sale. The topical cream was formulated to provide superior absorption of MedRelief’s Cannabidol strain. The cream mixes and integrates with the cannabis oil to create an easy-to-use topical agent for direct application to affected areas, the company says, and comes with easy-to-follow mixing instructions.
FOR MORE INFORMATION: https://medreleaf.com/cream
The US Food and Drug Administration granted 510(k) clearance to Solta Medical’s Thermage FLX System in early October. The next generation Thermage technology features a new optimized energy delivery algorithm, which automatically measures and precisely tunes the amount of energy delivered to the patient and treatment area, the company says. The system also has a new vibrating hand-piece to help enhance patient comfort, and a new, larger treatment tip that reduces treatment time by 25%. Radiofrequency technology uniformly and gently heats deep collagen-rich layers of the skin to tighten existing collagen and stimulate the production of new collagen, the company says.
FOR MORE INFORMATION: http://www.solta.com
Sonoma Pharmaceuticals, Inc., announced the U.S. commercialization of Loyon, which is intended to manage and relieve the scaling, erythema, and itching associated with various types of dermatoses including seborrhea and seborrheic dermatitis, the company says. The formula combines the dry emollient Cetiol CC and the medical silicone oil dimethicone. The product received a new 510(k) clearance from the U.S. Food and Drug Administration in March 2017.
FOR MORE INFORMATION: www.intraderm.com
ALASTIN Skincare announced the launch of the TriHex Transition Duo at the October American Society for Dermatologic Surgery Annual Meeting in Chicago. Together, the products prepare the skin for rejuvenating procedures, support healing and outcomes post-procedure, and ensure a smooth transition to ongoing skin care maintenance after healing to help maintain the benefits of the procedure. The pack includes a full-size Regenerating Skin Nectar for pre- and post-procedure use and a transition-size Restorative Skin Complex for ongoing maintenance.
FOR MORE INFORMATION: https://www.alastin.com